Self-immolative anthracycline prodrugs for suicide gene therapy

被引：36

作者：

Niculescu-Duvaz, I ^{[1
]}

Niculescu-Duvaz, D ^{[1
]}

Friedlos, F ^{[1
]}

Spooner, R ^{[1
]}

Martin, J ^{[1
]}

Marais, R ^{[1
]}

Springer, CJ ^{[1
]}

机构：

[1] Inst Canc Res, CRC, Ctr Canc Therapeut, Sutton SM2 5NG, Surrey, England

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 1999年 / 42卷 / 13期

关键词：

D O I：

10.1021/jm980696v

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Four novel potential prodrugs derived from daunorubicin (8, 10) and doxorubicin (12, 14) were designed and synthesized. They are self-immolative prodrugs for suicide gene therapy activation by the enzyme carboxypeptidase G2 (CPG2) subsequently releasing the corresponding anthracyclines, by a 1,6-elimination mechanism. A mammary carcinoma cell line (MDA MB 361) was engineered to express CPG2 intracellularly (CPG2*) or extracellularly, tethered to the outer cell membrane (stCPG2(Q)3). The prodrugs derived from doxorubicin showed prodrug/drug cytotoxicity differentials of 21-fold (compound 12) and 23-fold (compound 14). Prodrug 12 underwent an 11-fold activation when assayed in the cell line expressing externally surface-tethered CPG2.

引用

页码：2485 / 2489

页数：5

共 35 条

[11]

HAISMA HJ, 1994, CELL BIOPHYS, V24-5, P185, DOI 10.1007/BF02789229

[12] A MONOCLONAL ANTIBODY-BETA-GLUCURONIDASE CONJUGATE AS ACTIVATOR OF THE PRODRUG EPIRUBICIN-GLUCURONIDE FOR SPECIFIC TREATMENT OF CANCER [J].

HAISMA, HJ ;

BOVEN, E ;

VANMUIJEN, M ;

DEJONG, J ;

VANDERVIJGH, WJF ;

PINEDO, HM .

BRITISH JOURNAL OF CANCER, 1992, 66 (03) :474-478

[13] Deprotection of allyl groups with sulfinic acids and palladium catalyst [J].

Honda, M ;

Morita, H ;

Nagakura, I .

JOURNAL OF ORGANIC CHEMISTRY, 1997, 62 (25) :8932-8936

[14] RETROVIRAL-MEDIATED GENE-THERAPY FOR THE TREATMENT OF HEPATOCELLULAR-CARCINOMA - AN INNOVATIVE APPROACH FOR CANCER-THERAPY [J].

HUBER, BE ;

RICHARDS, CA ;

KRENITSKY, TA .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (18) :8039-8043

[15]

JUNGHEIM LN, 1993, HETEROCYCLES, V35, P339

[16]

KERR DE, 1995, CANCER RES, V55, P3558

[17] ANTIBODY-PENICILLIN-V-AMIDASE CONJUGATES KILL ANTIGEN-POSITIVE TUMOR-CELLS WHEN COMBINED WITH DOXORUBICIN PHENOXYACETAMIDE [J].

KERR, DE ;

SENTER, PD ;

BURNETT, WV ;

HIRSCHBERG, DL ;

HELLSTROM, I ;

HELLSTROM, KE .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 1990, 31 (04) :202-206

[18] Synthesis and evaluation of novel daunomycin-phosphate -sulfate -beta-glucuronide and -beta-glucoside prodrugs for application in ADEPT. [J].

Leenders, RGG ;

Scheeren, HW ;

Houba, PHJ ;

Boven, E ;

Haisma, HJ .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1995, 5 (24) :2975-2980

[19] A cell surface tethered enzyme improves efficiency in gene-directed enzyme prodrug therapy [J].

Marais, R ;

Spooner, RA ;

Stribbling, SM ;

Light, Y ;

Martin, J ;

Springer, CJ .

NATURE BIOTECHNOLOGY, 1997, 15 (13) :1373-1377

[20]

Marais R, 1996, CANCER RES, V56, P4735

← 1 2 3 4 →